Philadelphia, Pennsylvania
Phase 1 cancer trials in Philadelphia, PA
104 Phase 1 cancer studies are recruiting participants at sites in Philadelphia as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Philadelphia at a glance
- 104 studies are recruiting at a site in Philadelphia.
- By phase: Early Phase 1 (5), Phase 1 (49), Phase 1/2 (50).
- By sponsor: industry (75), university, hospital or other (27), government (2).
- By research area: Lung Cancer (34), Lymphoma (30), Breast Cancer (17), Prostate Cancer (14), Melanoma (7), Pancreatic Cancer (2).
- Most recent update to one of these records: November 17, 2026.
Breast cancer studies recruiting in Philadelphia
Basic details from each study's public record (the 30 most recently updated of 104). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- ORIC Pharmaceuticals
- Study site
- University of Pennsylvania
- Registry record
- NCT05315700 · updated
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Phase 1
- Ages 19 and older
- All sexes
- Sponsor
- NiKang Therapeutics, Inc.
- Study site
- Sidney Kimmell Cancer Center - Jefferson Health
- Registry record
- NCT06586957 · updated
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study sites
- Fox Chase Cancer Center · University of Pennsylvania
- Registry record
- NCT07213791 · updated
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
- Phase 1/2
- Ages 18 and older
- Female participants
- Sponsor
- Hoffmann-La Roche
- Study site
- Thomas Jefferson University Hospital
- Registry record
- NCT04802759 · updated
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- LigaChem Biosciences, Inc.
- Study site
- Sidney Kimmel Comprehensive Center at Jefferson
- Registry record
- NCT06774963 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Philadelphia, PA on ClinicalTrials.gov.
Lung cancer studies recruiting in Philadelphia
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Study site
- Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University
- Registry record
- NCT07277413 · updated
Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Study site
- Abramson Cancer Center of the University of Pennsylvania
- Registry record
- NCT03760575 · updated
A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kestrel Therapeutics, Inc.
- Study site
- Sidney Kimmel Cancer Center
- Registry record
- NCT07458347 · updated
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Study site
- Univ of Pennsylvania, Abramson Cancer Center
- Registry record
- NCT07020221 · updated
Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
- Phase 1/2
- Ages 12 to 85
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Hospital of the University of Pennsylvania
- Registry record
- NCT04959175 · updated
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BlossomHill Therapeutics
- Study site
- Thomas Jefferson University, Sidney Kimmel Cancer Center
- Registry record
- NCT06706076 · updated
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kumquat Biosciences Inc.
- Study site
- Sydney Kimmel Cancer Center
- Registry record
- NCT06720987 · updated
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kumquat Biosciences Inc.
- Study site
- Fox Chase Cancer Center
- Registry record
- NCT07542704 · updated
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Pierre Fabre Medicament
- Study site
- Thomas Jefferson University Research Facility
- Registry record
- NCT06043817 · updated
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Abramson Cancer Center of the University of Pennsylvania ( Site 0010)
- Registry record
- NCT04165070 · updated
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Synthekine
- Study site
- Fox Chase Cancer Center
- Registry record
- NCT05098132 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Philadelphia, PA on ClinicalTrials.gov.
Prostate cancer studies recruiting in Philadelphia
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Amgen
- Study site
- Thomas Jefferson University
- Registry record
- NCT04221542 · updated
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
- Phase 1/2
- Ages 18 and older
- Male participants
- Sponsor
- GlaxoSmithKline
- Study site
- GSK Investigational Site
- Registry record
- NCT07332455 · updated
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Regeneron Pharmaceuticals
- Study site
- Thomas Jefferson University Hospital
- Registry record
- NCT03972657 · updated
A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Sidney Kimmel Cancer Center - Jefferson Health
- Registry record
- NCT05818683 · updated
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Sidney Kimmel Cancer Center - Jefferson Health
- Registry record
- NCT06095089 · updated
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Phase 1
- Ages 18 to 100
- Male participants
- Sponsor
- Janux Therapeutics
- Study site
- Thomas Jefferson University Honickman Center
- Registry record
- NCT05519449 · updated
FTT PET/CT in Metastatic Prostate Cancer
- Early Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Study site
- University of Pennsylvania Hospital
- Registry record
- NCT05242744 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Philadelphia, PA on ClinicalTrials.gov.
Lymphoma studies recruiting in Philadelphia
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Study sites
- Children's Hospital of Philadelphia · Saint Christopher's Hospital for Children
- Registry record
- NCT04726241 · updated
Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Study site
- Abramson Cancer Center, University of Pennsylvania
- Registry record
- NCT07478848 · updated
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
- Phase 1
- Ages 0 to 18
- All sexes
- Sponsor
- Autolus Limited
- Study site
- Children's Hospital of Philadelphia
- Registry record
- NCT06173518 · updated
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- Nuvalent Inc.
- Study site
- University of Pennsylvania, Abramson Cancer Center
- Registry record
- NCT05384626 · updated
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- University of Pennsylvania Abramson Cancer Center
- Registry record
- NCT07101328 · updated
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Phase 1/2
- From 6 months, up to 25 years
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Children's Hospital of Philadelphia (CHOP) ( Site 1021)
- Registry record
- NCT06395103 · updated
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
- Early Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- AIDS Malignancy Consortium
- Study site
- University of Pennsylvania
- Registry record
- NCT04139304 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Philadelphia, PA on ClinicalTrials.gov.
Ask about studies near Philadelphia
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Pennsylvania
All Pennsylvania locations
167 studies recruiting across 13 cities.
Pittsburgh
71 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections